Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Oct;35(10):1965–1974. doi: 10.1128/aac.35.10.1965

Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii.

J C Comley 1, R J Mullin 1, L A Wolfe 1, M H Hanlon 1, R Ferone 1
PMCID: PMC245309  PMID: 1759815

Abstract

Pneumocystis carinii inoculated into 96-well filtration plate assemblies was shown to synthesize radiolabeled folates de novo from [para-3H]aminobenzoic acid ([3H]pABA). At the end of each incubation with [3H]pABA, a vacuum manifold was used to remove the medium and wash P. carinii. The membrane at the base of each well was dried and punched out, and the level of 3H retained was determined by direct scintillation counting. High-pressure liquid chromatography analysis of duplicate filters confirmed that direct counting of 3H retained on membranes (after correction for unmetabolized [3H]pABA) was an accurate reflection of total [3H]pABA incorporation by P. carinii. Greater than 95% of the 3H recovered was shown to be present as polyglutamated species. After digestion with rat plasma folic acid gamma-glutamyl hydrolase, para-aminobenzoylglutamate, N10-formyltetrahydrofolate, and tetrahydrofolate were identified as the major 3H-labeled components. para-Aminobenzoylglutamate was presumed to have arisen from folylpolyglutamates synthesized by P. carinii and was therefore included in the calculation of total [3H]pABA incorporation. P. carinii incorporation of [3H]pABA under optimal conditions was used as a selective measure of in vitro viability against which the inhibitory effects of some antipneumocystis agents (pentamidine, sulfamethoxazole, 566C80, and piritrexim) were quantitated. The concentrations of pentamidine, sulfamethoxazole, 566C80, and piritrexim required for 50% inhibition in this assay were 7.3, 0.1, 1.4, and approximately 100 microM, respectively. The results suggest that this 96-well [3H]pABA incorporation assay has considerable potential for objective in vitro drug screening against P. carinii.

Full text

PDF
1965

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett M. S., Eichholtz R., Smith J. W. Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis. 1985 Sep;3(5):381–387. doi: 10.1016/0732-8893(85)90076-8. [DOI] [PubMed] [Google Scholar]
  2. Bartlett M. S., Fishman J. A., Durkin M. M., Queener S. F., Smith J. W. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol. 1990 Jan;70(1):100–106. doi: 10.1016/0014-4894(90)90089-u. [DOI] [PubMed] [Google Scholar]
  3. Cushion M. T., Ebbets D. Growth and metabolism of Pneumocystis carinii in axenic culture. J Clin Microbiol. 1990 Jun;28(6):1385–1394. doi: 10.1128/jcm.28.6.1385-1394.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cushion M. T., Ruffolo J. J., Linke M. J., Walzer P. D. Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA13 human cell lines. Exp Parasitol. 1985 Aug;60(1):43–54. doi: 10.1016/s0014-4894(85)80021-7. [DOI] [PubMed] [Google Scholar]
  5. Cushion M. T., Stanforth D., Linke M. J., Walzer P. D. Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro. Antimicrob Agents Chemother. 1985 Dec;28(6):796–801. doi: 10.1128/aac.28.6.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duch D. S., Bowers S. W., Nichol C. A. Analysis of folate cofactor levels in tissues using high-performance liquid chromatography. Anal Biochem. 1983 Apr 15;130(2):385–392. doi: 10.1016/0003-2697(83)90604-8. [DOI] [PubMed] [Google Scholar]
  8. Hanlon M. H., Ferone R., Mullin R. J., Keith B. R. In vivo and in vitro metabolism of 5-deazaacyclotetrahydrofolate, an acyclic tetrahydrofolate analogue. Cancer Res. 1990 Jun 1;50(11):3207–3211. [PubMed] [Google Scholar]
  9. Horne D. W., Krumdieck C. L., Wagner C. Properties of folic acid gamma-glutamyl hydrolase (conjugase) in rat bile and plasma. J Nutr. 1981 Mar;111(3):442–449. doi: 10.1093/jn/111.3.442. [DOI] [PubMed] [Google Scholar]
  10. Hughes W. T. Animal models for Pneumocystis carinii pneumonia. J Protozool. 1989 Jan-Feb;36(1):41–45. doi: 10.1111/j.1550-7408.1989.tb02688.x. [DOI] [PubMed] [Google Scholar]
  11. Hughes W. T., Gray V. L., Gutteridge W. E., Latter V. S., Pudney M. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1990 Feb;34(2):225–228. doi: 10.1128/aac.34.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jackson P. R., Pappas M. G., Hansen B. D. Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa. Science. 1985 Jan 25;227(4685):435–438. doi: 10.1126/science.2578226. [DOI] [PubMed] [Google Scholar]
  13. Jones S. K., Hall J. E., Allen M. A., Morrison S. D., Ohemeng K. A., Reddy V. V., Geratz J. D., Tidwell R. R. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1990 Jun;34(6):1026–1030. doi: 10.1128/aac.34.6.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kovacs J. A., Allegra C. J., Beaver J., Boarman D., Lewis M., Parrillo J. E., Chabner B., Masur H. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents. J Infect Dis. 1989 Aug;160(2):312–320. doi: 10.1093/infdis/160.2.312. [DOI] [PubMed] [Google Scholar]
  15. Kovacs J. A., Masur H. Prophylaxis of Pneumocystis carinii pneumonia: an update. J Infect Dis. 1989 Nov;160(5):882–886. doi: 10.1093/infdis/160.5.882. [DOI] [PubMed] [Google Scholar]
  16. Lapinsky S. E., Glencross D., Car N. G., Kallenbach J. M., Zwi S. Quantification and assessment of viability of Pneumocystis carinii organisms by flow cytometry. J Clin Microbiol. 1991 May;29(5):911–915. doi: 10.1128/jcm.29.5.911-915.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MATHEWS C. K., HUENNEKENS F. M. Enzymic preparation of the 1,L-diastereoisomer of tetrahydrofolic acid. J Biol Chem. 1960 Nov;235:3304–3308. [PubMed] [Google Scholar]
  18. Monk J. P., Benfield P. Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia. Drugs. 1990 May;39(5):741–756. doi: 10.2165/00003495-199039050-00008. [DOI] [PubMed] [Google Scholar]
  19. Pesanti E. L., Cox C. Metabolic and synthetic activities of Pneumocystis carinii in vitro. Infect Immun. 1981 Dec;34(3):908–914. doi: 10.1128/iai.34.3.908-914.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pesanti E. L. In vitro effects of antiprotozoan drugs and immune serum on Pneumocystis carinii. J Infect Dis. 1980 Jun;141(6):775–780. doi: 10.1093/infdis/141.6.775. [DOI] [PubMed] [Google Scholar]
  21. Pifer L. L., Pifer D. D., Woods D. R. Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture. Antimicrob Agents Chemother. 1983 Nov;24(5):674–678. doi: 10.1128/aac.24.5.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pifer L. L., Woods D., Hughes W. T. Propagation of Pneumocystis carinii in Vero cell culture. Infect Immun. 1978 Apr;20(1):66–68. doi: 10.1128/iai.20.1.66-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Queener S. F., Bartlett M. S., Jay M. A., Durkin M. M., Smith J. W. Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother. 1987 Sep;31(9):1323–1327. doi: 10.1128/aac.31.9.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Thomson R. B., Jr, Smith T. F. Acridine orange staining of Pneumocystis carinii. J Clin Microbiol. 1982 Jul;16(1):191–192. doi: 10.1128/jcm.16.1.191-192.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yamada M., Matsumoto Y., Hamada S., Fujita S., Yoshida Y. Demonstration and determination of DNA in Pneumocystis carinii by fluorescence microscopy with 4', 6-diamidino-2-phenylindole (DAPI). Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Aug;262(2):240–246. doi: 10.1016/s0176-6724(86)80025-6. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES